Format

Send to

Choose Destination
Future Microbiol. 2016;11(1):153-64. doi: 10.2217/fmb.15.110. Epub 2015 Dec 17.

DNA-based influenza vaccines as immunoprophylactic agents toward universality.

Author information

1
Department of Microbiology & Immunology, Emory University School of Medicine, Atlanta, Georgia 30322, USA.
2
Biomedical Research Center, Vice President Office for Research, Qatar University, Doha 2713, Qatar.

Abstract

Influenza is an illness of global public health concern. Influenza viruses have been responsible for several pandemics affecting humans. Current influenza vaccines have proved satisfactory safety; however, they have limitations and do not provide protection against unexpected emerging influenza virus strains. Therefore, there is an urgent need for alternative approaches to conventional influenza vaccines. The development of universal influenza vaccines will help alleviate the severity of influenza pandemics. Influenza DNA vaccines have been the subject of many studies over the past decades due to their ability to induce broad-based protective immune responses in various animal models. The present review highlights the recent advances in influenza DNA vaccine research and its potential as an affordable universal influenza vaccine.

KEYWORDS:

DNA vaccines; delivery; immunoprophylaxis; influenza; pandemics; universal; virus

PMID:
26673424
DOI:
10.2217/fmb.15.110
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Atypon
Loading ...
Support Center